CN103951733A - 一种人肿瘤抑制蛋白变体及其应用 - Google Patents
一种人肿瘤抑制蛋白变体及其应用 Download PDFInfo
- Publication number
- CN103951733A CN103951733A CN201410131815.3A CN201410131815A CN103951733A CN 103951733 A CN103951733 A CN 103951733A CN 201410131815 A CN201410131815 A CN 201410131815A CN 103951733 A CN103951733 A CN 103951733A
- Authority
- CN
- China
- Prior art keywords
- variant
- protein variant
- human tumor
- protein
- kiaa0157
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 20
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 11
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 9
- 235000018102 proteins Nutrition 0.000 claims description 15
- 102220538475 Methionine-tRNA ligase, cytoplasmic_K85P_mutation Human genes 0.000 claims description 7
- 102220205652 rs1057522121 Human genes 0.000 claims description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 3
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
- 101000760684 Homo sapiens BRISC complex subunit Abraxas 2 Proteins 0.000 description 18
- 102100024635 BRISC complex subunit Abraxas 2 Human genes 0.000 description 16
- 238000000034 method Methods 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 239000002609 medium Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 230000035519 G0 Phase Effects 0.000 description 4
- 230000010190 G1 phase Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 108091007065 BIRCs Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000018486 cell cycle phase Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 101150107671 hisB gene Proteins 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000000225 tumor suppressor protein Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410131815.3A CN103951733B (zh) | 2014-04-02 | 2014-04-02 | 一种人肿瘤抑制蛋白变体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410131815.3A CN103951733B (zh) | 2014-04-02 | 2014-04-02 | 一种人肿瘤抑制蛋白变体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103951733A true CN103951733A (zh) | 2014-07-30 |
CN103951733B CN103951733B (zh) | 2017-02-15 |
Family
ID=51329107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410131815.3A Expired - Fee Related CN103951733B (zh) | 2014-04-02 | 2014-04-02 | 一种人肿瘤抑制蛋白变体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103951733B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106349362A (zh) * | 2016-11-09 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349366A (zh) * | 2016-11-14 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349365A (zh) * | 2016-11-14 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349364A (zh) * | 2016-11-10 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349360A (zh) * | 2016-11-09 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349358A (zh) * | 2016-11-07 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349363A (zh) * | 2016-11-10 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349361A (zh) * | 2016-11-09 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349359A (zh) * | 2016-11-07 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106397566A (zh) * | 2016-11-07 | 2017-02-15 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106397567A (zh) * | 2016-11-08 | 2017-02-15 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106432464A (zh) * | 2016-11-08 | 2017-02-22 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106432465A (zh) * | 2016-11-08 | 2017-02-22 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106432466A (zh) * | 2016-11-10 | 2017-02-22 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106478799A (zh) * | 2016-11-14 | 2017-03-08 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1376705A (zh) * | 2001-03-22 | 2002-10-30 | 上海博德基因开发有限公司 | 一种多肽——人大蛋白-34.98和编码这种多肽的多核苷酸 |
CN101712958A (zh) * | 2008-10-08 | 2010-05-26 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种新的人肿瘤抑制基因kiaa0157及其应用 |
-
2014
- 2014-04-02 CN CN201410131815.3A patent/CN103951733B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1376705A (zh) * | 2001-03-22 | 2002-10-30 | 上海博德基因开发有限公司 | 一种多肽——人大蛋白-34.98和编码这种多肽的多核苷酸 |
CN101712958A (zh) * | 2008-10-08 | 2010-05-26 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种新的人肿瘤抑制基因kiaa0157及其应用 |
Non-Patent Citations (1)
Title |
---|
EAW49265.1: "KIAA0157,isoform CRA_a", 《GENBANK》, 4 February 2010 (2010-02-04), pages 2 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106397566A (zh) * | 2016-11-07 | 2017-02-15 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349358A (zh) * | 2016-11-07 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349359A (zh) * | 2016-11-07 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106432465A (zh) * | 2016-11-08 | 2017-02-22 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106432464A (zh) * | 2016-11-08 | 2017-02-22 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106397567A (zh) * | 2016-11-08 | 2017-02-15 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349362A (zh) * | 2016-11-09 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349360A (zh) * | 2016-11-09 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349361A (zh) * | 2016-11-09 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349364A (zh) * | 2016-11-10 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349363A (zh) * | 2016-11-10 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106432466A (zh) * | 2016-11-10 | 2017-02-22 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349365A (zh) * | 2016-11-14 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106349366A (zh) * | 2016-11-14 | 2017-01-25 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
CN106478799A (zh) * | 2016-11-14 | 2017-03-08 | 李露青 | 一种人肿瘤抑制蛋白变体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103951733B (zh) | 2017-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103951733A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN103951743A (zh) | 人sfrp1变体及其应用 | |
CN103103169B (zh) | 一种植物抗旱相关蛋白EeSnRK2.4及其编码基因和应用 | |
CN105349505B (zh) | 一种植物抗旱、耐盐相关蛋白AsSnRK及其编码基因和应用 | |
CN103497940A (zh) | 一种植物抗旱相关蛋白TaSnRK2.6及其编码基因和应用 | |
CN106636032B (zh) | 一种植物抗旱相关蛋白EeSnRK2.7及其编码基因和应用 | |
CN106636031A (zh) | 植物抗旱相关蛋白AsTMK1及其编码基因和应用 | |
CN106397567A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106478799A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106397566A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106432465A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106432464A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106432466A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349365A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349366A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
Gatti et al. | Variation with sex of irradiation-induced chromosome damage in somatic cells of Drosophila melanogaster | |
CN106349363A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349362A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349360A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349361A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349359A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349364A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN106349358A (zh) | 一种人肿瘤抑制蛋白变体及其应用 | |
CN104450784B (zh) | 一种samhd1基因敲除细胞系的构建方法 | |
CN106636030A (zh) | 植物抗旱相关蛋白EtSnRK2.2及其编码基因和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161206 Address after: 315113 Zhejiang city of Ningbo province Yinzhou District east Wu Town Road No. 58 Applicant after: Zhu Yupan Address before: Yinzhou District Heng Jie Heng Jie Zhen Road 315181 No. 50 Zhejiang city of Ningbo Province Applicant before: Hua Guoguang |
|
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Jiayue Inventor before: Hua Guoguang |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170117 Address after: Yuci District 030600 of Shanxi province Jinzhong City Yingbin Street No. 115 Applicant after: SHANXI SEQUOIA PHARMACEUTICAL Co.,Ltd. Address before: 315113 Zhejiang city of Ningbo province Yinzhou District east Wu Town Road No. 58 Applicant before: Zhu Yupan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170215 |
|
CF01 | Termination of patent right due to non-payment of annual fee |